TransMedics creates new Organ Care System being used in Australia

By Uwear

A group of United States scientists called TransMedics has created a new, innovative medical technology that mimics the conditions of the human body and may help replenish the low supply of hearts for transplantation by 30 per cent.

Rather than keeping hearts or other organs on ice until it reaches the recipient, the new technology called Organ Care System (OCS) is designed to maintain organs in a warm, functioning state outside of the body.

RELATED TOPIC: 4WEB Medical brings 3D printing implants to Australia

This portable machine has led to a new type of organ transplant referred to a living organ transplant. It increases the amount of time an organ and be maintained outside of the body, gives surgeons a chance to assess the function of the organ outside the body and allows resuscitation of the organ once removed from its deceased owner.

If the OCS is approved for medical use in the U.S., it will provide a solution for the thousands of Americans who require a heart transplant each year. It has already been used in 15 successful heart transplants in Australia and the United Kingdom.

OCS, a $250,000 device, essentially consists of a sterile chamber containing oxygen, blood and nutrient supply to the heart, which keeps the heart pumping outside of the human body until it is ready for transplant.

RELATED TOPIC: Should Australia look to become more friendly to medical tourism?

The process increases the number of hearts available by reviving the heart of brain dead patients as well as reanimating hearts of recently deceased patients. In addition, OCS allows the surgical team to remove the heart of dead people and bring it back to life for transplants.

Earlier this year, surgeons at St. Vincent’s Hospital in New South Wales discussed three cases where they waited as little as two minutes after a person’s heart stopped before removing it. They then attached it to the TransMedics device within 20 minutes, and it began beating again.

Without this technology, surgeons would normally consider hearts from dead donors as too damaged for transplantation.

RELATED TOPIC: South Korean economy takes hit after MERS outbreak

“The device is vital,” said Stephen Large, a surgeon at the UK’s Papworth Hospital, which has used OCS as part of eight different transplants. “The heart gets an absolutely essential infusion of blood to restore its energy.”

Some believe the Transmedics’ machine is flawed, as it’s still too expensive and isn’t quite automated enough. But eventually, this may open the door to other organs such as livers to be recovered as long as an hour after death.

Let's connect!  

Check out the latest edition of Business Review Australia!



Featured Articles

Nirvik Singh, COO Grey Group on adding colour to campaigns

Nirvik Singh, Global COO and President International of Grey Group, cultivating culture and utilising AI to enhance rather than replace human creativity

How Longi became the world’s leading solar tech manufacturer

On a mission to accelerate the adoption of sustainable energy solutions, US$30 billion Chinese tech firm Longi is not just selling solar – but using it

How Samsung’s US$5billion sustainability plan is working out

Armed with an ambitious billion-dollar strategy, Samsung is on track to achieve net zero carbon emissions company-wide by 2050 – but challenges persist

UOB: making strides in sustainability across Southeast Asia


Huawei smartwatch goes for gold with Ultimate Edition


How IKEA India plans to double business, triple headcount

Corporate Finance